Acute corneal hydrops occurs secondary to a tear in the Descemet’s membrane and results from aqueous seepage into the stroma, forming fluid clefts. Conventionally, this is managed medically with ...
WASHINGTON, DC — Patients taking amantadine are at risk for corneal edema, according to investigators whose case study earned a "Top 5 Poster" award here at Optometry's Meeting by the American ...
Findings of post hoc analyses published in JAMA Ophthalmology suggest that preoperative Scheimpflug imaging can help predict corneal edema resolution following Descemet membrane endothelial ...
On the basis of this patient's ocular history (ie, ocular rubbing and allergies), acute onset of pain, and presence of corneal edema with bullae, the correct diagnosis is acute corneal hydrops. Acute ...
As reported by Henick and colleagues in 1994, removal of retained anterior chamber nuclear fragments after cataract surgery can lead to visual and symptomatic improvement. As surgical techniques and ...
This page lists all known medications that could potentially lead to 'Corneal stromal edema' as a side effect. It's important to note that mild side effects are quite common with medications. The ...
MENLO PARK, Calif., Oct. 8, 2024 /PRNewswire/ -- Emmetrope Ophthalmics, LLC ("Emmecell"), a clinical-stage biotechnology company pioneering the discovery and development of cell-based therapies for ...
The Food and Drug Administration recently approved a new contact lens for the treatment of corneal edema —an eye condition that causes swelling, fluid build up, blurred vision, haziness and scarring.
Dublin, Feb. 11, 2025 (GLOBE NEWSWIRE) -- The "Corneal Edema - Epidemiology Forecast - 2034" report has been added to ResearchAndMarkets.com's offering. A comprehensive report has been released ...
A 50-year-old gentleman presented to eye casualty with a 1 week history of reduced vision and headache above his left eye. He had a left corneal graft for keratoconus in 1988 and had not been seen by ...
MENLO PARK, Calif., Sept. 22, 2020 /PRNewswire/ -- Emmetrope Ophthalmics LLC ("Emmecell"), a clinical-stage biotechnology company pioneering the discovery and development of cell-based therapies for ...
TEL AVIV, Israel, June 8, 2021 /PRNewswire/ — EyeYon Medical, an Israeli start-up company developing a variety of ophthalmic products for vision-threatening conditions, announced today that it has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback